EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential

Peter R McHenry, Jenifer R Prosperi

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Peter R McHenry und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Science and Health, Faculty of Arts and Sciences, Middle East University, P.O. Box 90-481, Jdeidet El Metn 1202-2040, Lebanon. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cancer secretome comprises factors secreted by tumors, including cytokines, growth factors, proteins from the extracellular matrix (ECM), proteases and protease inhibitors, membrane and extracellular vesicle proteins, peptide hormones, and metabolic proteins. Secreted proteins provide an avenue for communication with other tumor cells and stromal cells, and these in turn promote tumor growth and progression. Breast cancer is the most commonly diagnosed cancer in women in the US and worldwide. Triple-negative breast cancer (TNBC) is characterized by its aggressiveness and its lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and HER2, making it unable to be treated with therapies targeting these protein markers, and leaving patients to rely on standard chemotherapy. In order to develop more effective therapies against TNBC, researchers are searching for targetable molecules specific to TNBC. Proteins in the TNBC secretome are involved in wide-ranging cancer-promoting processes, including tumor growth, angiogenesis, inflammation, the EMT, drug resistance, invasion, and development of the premetastatic niche. In this review, we catalog the currently known proteins in the secretome of TNBC tumors and correlate these secreted molecules with potential therapeutic opportunities to facilitate translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsHumansFemaleSecretomeStromal Cells

Stichwörter der Autor:innen

ECMTNBCangiogenesisbreast cancercytokineproteasesecretometherapeutic targettumor microenvironment

Autor:innen und Institutionen

  • Department of Natural Science and Health, Faculty of Arts and Sciences, Middle East University, P.O. Box 90-481, Jdeidet El Metn 1202-2040, Lebanon.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-South Bend, South Bend, IN 46617, USA.
  • Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.

Förderung

  • American Cancer Society

Zitieren

APA

McHenry, P. R., & Prosperi, J. R. (2023). Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032100

Vancouver

McHenry PR, Prosperi JR. Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032100

BibTeX
@article{McHenry2023,
  author = {McHenry, Peter R and Prosperi, Jenifer R},
  title = {Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032100}
}
Kostenlos starten →